# Assessment of Intravenous Rate Control Response in Atrial Fibrillation Trial (AIRCRAFT)

> **NCT04234477** · PHASE4 · WITHDRAWN · sponsor: **Boston University**

## Conditions studied

- Atrial Fibrillation

## Interventions

- **DRUG:** Beta-blocker strategy
- **DRUG:** Calcium channel blocker strategy
- **DRUG:** Physician preference strategy

## Key facts

- **NCT ID:** NCT04234477
- **Lead sponsor:** Boston University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2021-12
- **Primary completion:** 2022-06
- **Final completion:** 2022-06
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The study was not IRB approved and there were anticipated challenges in recruiting participants.
- **Last updated:** 2021-12-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04234477

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04234477, "Assessment of Intravenous Rate Control Response in Atrial Fibrillation Trial (AIRCRAFT)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04234477. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*